✦ LIBER ✦

Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10–45 years

✍ Scribed by Miguel W. Tregnaghi; Ricardo Voelker; Eduardo Santos-Lima; Betzana Zambrano

Book ID: 116962479
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 428 KB
Volume: 28
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2010.02.049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant-yeast-derived hepatitis b va

Recombinant-yeast-derived hepatitis b vaccine in healthy adults: Safety and two-year immunogenicity of early investigative lots of vaccine

✍ Lynn Butterly; Eloise Watkins; Jules L. Dienstag 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB

We tested the safety and long-term immunogenicity of two of the early investigative lots of a recombinant-yeast-derived hepatitis B vaccine in immunocompetent adults. Three 10-micrograms doses of recombinant hepatitis B vaccine (Merck Sharp & Dohme Research Laboratories, West Point, PA) were adminis

Comparison of safety and immunogenicity

Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age

✍ Scott A. Halperin; Brian Ward; Curtis Cooper; Gerald Predy; Francisco Diaz-Mitom 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 344 KB